e-therapeutics Plc announced the appointment of Karl Keegan as Chief Financial Officer, or CFO, with immediate effect. The CFO role will be a non-Board position one. Till recently, Keegan worked as Chief Executive Officer of privately-held Hox Therapeutics Ltd. He has helmed senior executive positions in both private and public companies since 2009. He brings to e-therapeutics more than 20 years-experience in the pharma and biotech industries.